Targeting PACAP: Beyond Migraine to Cluster, Menstrual, and Post-traumatic Headaches

Area of Science:

• Neuroscience
• Endocrinology
• Pain Research

Background:

• The pituitary adenylate cyclase-activating peptide (PACAP) pathway is increasingly recognized for its role in headache pathophysiology.
• PACAP interacts with specific receptors (PAC1, VPAC1, VPAC2) and influences neurovascular and hormonal regulation.
• Evidence links PACAP to trigeminal and parasympathetic system modulation, relevant in cluster headaches and menstrual migraine.

Purpose of the Study:

• To synthesize current evidence on the role of PACAP in headache disorders.
• To identify gaps in understanding PACAP's precise mechanisms in headache pathophysiology.
• To explore the therapeutic potential of targeting the PACAP pathway for headache management.

Main Methods:

• This study is a narrative review of existing scientific literature.
• The review synthesizes evidence from preclinical and clinical studies.
• Focus is placed on PACAP's involvement in various headache types and its therapeutic implications.

Main Results:

• PACAP plays a significant role in modulating pain pathways, including those involved in post-traumatic headaches.
• Early clinical trials targeting PACAP signaling have shown promising results, particularly in migraine prophylaxis.
• The PACAP pathway is implicated in the pathophysiology of cluster headaches and menstrual migraine.

Conclusions:

• The PACAP pathway is a potential therapeutic target for a range of headache disorders.
• Further research is needed to fully elucidate PACAP's mechanisms across diverse headache types.
• Successful clinical trials could lead to new treatments for millions suffering from headaches.